Journal of Thyroid Cancer

Journal of Thyroid Cancer

Journal of Thyroid Cancer – Submit Paper

Open Access & Peer-Reviewed

Submit Manuscript

Submit Your Thyroid Cancer Research

Join leading pathophysiology researchers advancing our understanding of thyroid cancer mechanisms, biomarkers, and molecular pathways

56% Acceptance Rate
21 Days to Decision
15 Minute Submission
Start Your Submission Now

Two Convenient Ways to Submit

We offer flexible submission options designed to accommodate your workflow. Choose the method that works best for your research submission needs.

Recommended

ManuscriptZone Portal

Our comprehensive manuscript management system provides full tracking, auto-save functionality, and real-time status updates throughout the peer review process.

  • Create secure account with manuscript dashboard
  • Auto-save feature prevents data loss
  • Track submission status in real-time
  • Receive reviewer comments directly
  • Upload revisions seamlessly
  • Access complete submission history

Best for: Researchers seeking complete manuscript management and transparent tracking from submission through publication.

Submit via ManuscriptZone
Fast Track

Quick Submission Form

A streamlined, single-page submission form for straightforward manuscripts. Perfect for authors who prefer a simple, direct submission process without account creation.

  • No account registration required
  • Single-page submission form
  • Fast and efficient process
  • Ideal for straightforward submissions
  • Immediate confirmation email
  • Direct upload of manuscript files

Best for: Quick submissions of complete manuscripts with all required documentation ready for immediate upload.

Use Quick Submission Form

Manuscript Types We Publish

Journal of Thyroid Cancer welcomes diverse research contributions that advance our understanding of thyroid cancer pathophysiology, from molecular mechanisms to translational biomarker studies. Each manuscript type undergoes rigorous peer review by experts in thyroid cancer research.

Original Research Articles

Comprehensive studies investigating thyroid cancer molecular mechanisms, signaling pathways, genetic alterations, tumor microenvironment, and disease progression models.

Biomarker Discovery Studies

Research identifying and validating novel diagnostic, prognostic, or predictive biomarkers for thyroid cancer, including molecular signatures, protein markers, and circulating biomarkers.

Mechanistic Studies

In-depth investigations of cellular and molecular mechanisms underlying thyroid cancer initiation, progression, metastasis, and therapeutic resistance using in vitro and in vivo models.

Systematic Reviews & Meta-Analyses

Comprehensive syntheses of existing research on thyroid cancer pathophysiology, molecular targets, biomarkers, or disease mechanisms following PRISMA guidelines.

Methods & Protocols

Novel experimental techniques, assay development, model systems, or analytical methods for studying thyroid cancer pathophysiology and molecular mechanisms.

Short Communications

Concise reports of preliminary findings, novel observations, or significant technical advances in thyroid cancer research that warrant rapid dissemination.

Case Reports

Detailed documentation of rare thyroid cancer presentations, unusual molecular profiles, or cases with significant pathophysiological insights and translational implications.

Review Articles

Comprehensive, critical evaluations of current knowledge in specific areas of thyroid cancer pathophysiology, molecular biology, or translational research.

Perspectives & Commentaries

Expert opinions on emerging trends, controversial topics, or future directions in thyroid cancer research, pathophysiology, and translational applications.

Discipline Focus: All submissions should emphasize pathophysiological mechanisms, molecular biology, biomarker development, or translational research aspects of thyroid cancer. Clinical management studies without mechanistic insights should be directed to clinical journals.

Pre-Submission Checklist

Ensure your manuscript is complete and properly formatted before submission. This checklist helps streamline the review process and reduces delays.

Manuscript File: Word (.docx) or LaTeX format, double-spaced, with line numbers
Title Page: Complete with all author names, affiliations, ORCID IDs, and corresponding author contact
Abstract: Structured abstract (250 words max) with Background, Methods, Results, Conclusions
Keywords: 5-8 relevant keywords for indexing and discoverability
Figures & Tables: High-resolution figures (300 DPI minimum, TIFF or EPS format preferred)
References: Formatted according to journal style, all citations verified
Ethics Approval: IRB/IACUC approval documentation for human or animal studies
Author Agreements: All authors have approved the manuscript and agree to submission
Competing Interests: Declaration of any financial or non-financial conflicts of interest
Cover Letter: Addressed to the editor, highlighting significance and novelty of your research
Supplementary Materials: All additional data files, videos, or supplementary figures properly labeled
Reporting Guidelines: Compliance with ARRIVE (animal studies) or CONSORT (clinical trials) as applicable

Transparent Peer Review Process

We believe in complete transparency. Here's exactly what happens after you submit your thyroid cancer research, with realistic timelines based on our actual performance data.

1

Initial Screening

Editorial office reviews your submission for completeness, formatting compliance, and scope alignment. Plagiarism check performed using iThenticate (manuscripts with >30% similarity returned for revision).

3 Days
2

Editor Assignment

Manuscript assigned to an Associate Editor with expertise in your specific area of thyroid cancer research (molecular mechanisms, biomarkers, disease models, etc.).

2 Days
3

Reviewer Selection

Editor identifies and invites 2-3 expert reviewers with specialized knowledge in thyroid cancer pathophysiology, molecular biology, or your specific research methodology.

5 Days
4

Peer Review

Expert reviewers evaluate scientific rigor, methodological soundness, data interpretation, and contribution to thyroid cancer research. Reviewers provide detailed feedback and recommendations.

21 Days
5

Editorial Decision

Editor synthesizes reviewer feedback and makes decision: Accept, Minor Revisions, Major Revisions, or Reject. You receive detailed reviewer comments and editor's guidance.

28 Days Total
6

Revision & Re-review

If revisions requested, you submit revised manuscript with point-by-point response to reviewers. Revised manuscripts undergo expedited re-review by original reviewers.

14 Days
7

Final Acceptance

Upon acceptance, manuscript proceeds to production. Copyediting, typesetting, and final author proofs completed. Article assigned DOI and prepared for publication.

10 Days
8

Online Publication

Your research is published online with immediate Open Access.

60 Days Total

Average Timeline: From submission to publication in approximately 60 days for manuscripts accepted without major revisions. This timeline reflects our commitment to rapid dissemination while maintaining rigorous peer review standards.

Why Thyroid Cancer Researchers Choose Us

We're committed to advancing thyroid cancer research through rigorous peer review, transparent processes, and global visibility for your work.

🔎

Expert Peer Review

Manuscripts reviewed by leading thyroid cancer researchers with expertise in pathophysiology, molecular mechanisms, and translational research

🕑

Fast Decisions

Average 21 days to first decision, with transparent timelines and regular status updates throughout the review process

🌐

Global Indexing

Indexed in major databases ensuring maximum visibility to the international thyroid cancer research community

🔒

Open Access

Immediate, unrestricted access to your research worldwide, maximizing citations and impact in the thyroid cancer field

Ethical Standards

Committed to COPE publication ethics, research integrity, and transparent review practices

💰

APC Waivers

Financial support available for eligible authors from low-income countries and unfunded research projects

Advancing Thyroid Cancer Pathophysiology Research

Journal of Thyroid Cancer is dedicated to publishing high-impact research that advances our mechanistic understanding of thyroid cancer. We prioritize studies that:

Elucidate molecular mechanisms underlying thyroid cancer initiation, progression, and metastasis
Identify and validate novel biomarkers for diagnosis, prognosis, or therapeutic response prediction
Characterize signaling pathways and cellular processes driving thyroid cancer pathophysiology
Develop and validate preclinical models for studying thyroid cancer mechanisms
Investigate genetic and epigenetic alterations contributing to thyroid cancer development
Explore tumor microenvironment interactions and their role in disease progression
Advance translational research bridging basic mechanisms to clinical applications
Develop novel methodologies for studying thyroid cancer pathophysiology

Our editorial board comprises internationally recognized experts in thyroid cancer research, molecular oncology, and translational pathophysiology. They ensure rigorous peer review while providing constructive feedback to enhance the quality and impact of your research.

Ready to Submit Your Research?

Join the global community of thyroid cancer researchers advancing our understanding of disease mechanisms and translational applications. Your research deserves a journal that understands your field.

Need Assistance?

Our editorial team is here to support you throughout the submission process. Whether you have questions about manuscript preparation, submission procedures, or journal scope, we're ready to help.

Contact us at: [email protected]